PG Electroplast Soars on Whirlpool Partnership and Ambitious Growth Plans

PG Electroplast shares surged 5.5% in early trading on December 24, hitting ₹1,002, as the company announced a strategic tie-up with Whirlpool of India. The agreement, revealed through a regulatory filing, positions PG Electroplast as a contract manufacturer for select Whirlpool-branded semi-automatic washing machines. PG Electroplast has cemented its reputation as a leading player in India’s electronic manufacturing services (EMS) space, working with top consumer durables and electronics brands. They’re betting on expanded capacities and capabilities to sustain their dominance in the consumer durables and plastics sector. To match this optimism, the company revised its FY25 revenue guidance to ₹4,250 crore—a remarkable 54.7% jump from FY24 levels. Net profit projections are equally ambitious, expected to climb 82.5% year-over-year to ₹250 crore. Operational efficiencies and robust cash flow management underpin these forecasts.

Biocon Rallies on Regulatory Wins and EU Approval

Biocon’s shares soared 5% on Tuesday, December 24, closing at ₹344.80 after hitting an intraday high of ₹347.35. The rally was fueled by two significant developments that strengthened investor confidence in the company’s growth trajectory. The first boost came from the United States Food and Drug Administration (USFDA), which issued an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status for Biocon’s Active Pharmaceutical Ingredients (API) facility in Bengaluru. Adding further momentum, Biocon announced that its European partner, Zentiva, received a decentralised procedure approval in the European Union (EU) for Liraglutide, a complex formulation used to treat Type-2 diabetes and manage weight. Biocon’s stock, which has already gained 35% year-to-date, reflected the optimism around these developments. The Bengaluru-based biopharma giant is clearly on a roll, leveraging strategic partnerships and regulatory approvals to solidify its presence in both the API and biosimilar markets.

Avaada Group Aims to Raise $1 Billion

Avaada Group is setting its sights on raising $1 billion (over ₹8,400 crore) in debt by March next year to fund its ambitious green energy projects, including wind, solar, and battery storage initiatives. Chairman Vineet Mittal shared with FE that the group has already raised equity and is now turning to debt to accelerate its growth. With an operational capacity of 4.7 gigawatts (GW), Avaada is targeting 11 GW by 2026 and 30 GW by 2030. Mittal emphasized that achieving 30 GW could happen sooner if the necessary transmission lines are developed. The group’s energy portfolio also includes 5 gigawatt-hours (GWh) of battery storage and 10 GWh of long-duration pumped hydel storage. Alongside its solar ventures, Avaada has an operational 1.5 GW solar plant in Noida. In parallel, Tata Power has also invested in solar manufacturing, with a 4 GW solar cell and module plant in Tamil Nadu that began operations last year. Additionally, Avaada is expanding into green ammonia and green hydrogen projects in Gopalpur, Odisha, with $1.8 billion secured from REC to fund its production facility in the Gopalpur Industrial Park.

Intellect Design Arena rise 13%

Shares of Intellect Design Arena rallied 13% on Monday, December 23, reaching an intraday high of ₹925.55, as investors cheered the company’s newly launched Enterprise AI platform, Purple Fabric. The surge comes on the heels of a detailed presentation on December 19, where the company introduced the platform designed to revolutionize operations in the financial and insurance sectors. Purple Fabric stands out for its ‘Multi-Agent’ AI system, which aims to streamline enterprise processes like claims settlement and tackle the growing data complexity in financial services. Built on Large Language Models (LLMs), the platform promises intuitive data integration and classification, empowering organizations to deliver seamless customer experiences without requiring deep technical expertise. The stock, now 23% shy of its 52-week high of ₹1,198.80 from March 2024, has rebounded impressively, up 33% from its November low of ₹693.05. December alone has seen a sharp 28% climb, marking a turnaround after three consecutive months of losses.

Steel Stocks Rally as India Probes Rising Imports

India’s steel sector was buzzing with action as shares of key players saw gains of up to 3.2% on the BSE. The trigger was a government probe into a surge in imports of specific steel flat products following a complaint by the Indian Steel Association (ISA). Meanwhile, Tata Steel and SAIL both saw their stocks rise by 2%, reflecting optimism within the industry. The probe, initiated by the Directorate General of Trade Remedies (DGTR), focuses on Non-Alloy and Alloy Steel Flat Products—a category vital to industries like construction, fabrication, auto, and electricals. The ISA claims a “recent, sudden, sharp, and significant” rise in imports is causing harm to domestic producers, sparking calls for protective measures. The applicant, backed by heavyweights like ArcelorMittal Nippon Steel India, JSW Steel, Jindal Steel & Power, and SAIL, has asked for a 20% safeguard duty on the imports, citing “critical circumstances” and the risk of injury to India’s steel industry.

CCI’s Year in Review

This year has been a whirlwind for the Competition Commission of India (CCI). From ramping up regulatory tools to taking on Big Tech, the watchdog has had its hands full redefining competition law in the digital age. One standout moment was March’s introduction of two key mechanisms: commitment and settlement—game-changers designed to cut litigation and enable faster market fixes. Alongside, the leniency-plus facility added muscle to cartel detection, further sharpening the CCI’s enforcement toolkit. The regulator didn’t stop there. September saw the debut of a deal value threshold (DVT) for M&A activity exceeding ₹2,000 crore, specifically targeting stealthy start-up acquisitions by tech giants. This shift reflects the CCI’s growing focus on curbing “killer” acquisitions—where Big Tech buys out small, innovative firms before they become market competitors.

SEBI Halts Trading in Bharat Global Developers

Bharat Global Developers Ltd. (BGDL) just became the poster child for what can go wrong when financial shenanigans meet unchecked market euphoria. The scandal comes on the back of an eyebrow-raising run: BGDL’s stock price soared 105 times in a year, climbing from ₹16.14 in late 2023 to a jaw-dropping ₹1,702.95 by November 2024. Such an astronomical rise was bound to draw scrutiny, and it seems the numbers just didn’t add up. A shady preferential allotment of shares, concentrated ownership (99.5% of shares in a few hands), fake partnerships with industry giants like Reliance and Tata, and a Dubai subsidiary that exists only in fantasy. Top this off with insider sell-offs netting over ₹270 crore in profits, and you’ve got a fraud cocktail potent enough to floor any regulator. SEBI’s findings are scathing. BGDL’s meteoric revenue growth had no real contracts or operations to back it up. The management overhaul in 2023 looks more like a smoke screen than a turnaround. Now, trading in BGDL is suspended, and SEBI has barred preferential allottees from any dealings in its securities.

India Cements Soars 11% as CCI Clears UltraTech Deal

ndia Cements shares skyrocketed 11%, touching ₹376.30 on the BSE, as the Competition Commission of India (CCI) gave the green light to UltraTech Cement’s strategic acquisition and open offer for a 32.72% equity stake in the company. On the flip side, UltraTech Cement shares saw a modest 1.4% climb, hitting ₹11,585.40. UltraTech’s board approved the acquisition of over 10.13 crore shares from promoters and key shareholders in India Cements, marking the “primary acquisition.” On top of that, they made an open offer to public shareholders for another 8.05 crore shares at ₹390 apiece. With CCI’s unconditional nod under Section 31(1) of the Competition Act, 2002, the deal is set to move forward seamlessly. India Cements’ stock has been on a tear, boasting a 47.12% surge in the past year and a 41.77% gain in 2024 alone. Even in the short term, it’s holding strong with a 4% uptick in the last month. With an RSI hovering near 35—firmly in the mid-range—the stock isn’t overbought, leaving room for more action as UltraTech solidifies its stake in the cement giant.

Sterling and Wilson Shares Spark

Sterling and Wilson Renewable Energy lit up the market, with shares climbing over 6% after the company bagged a hefty ₹1,200 crore order in Gujarat. The stock hit a high of ₹471 on the BSE before settling slightly lower, marking a 6.81% surge. A 500 MW Solar PV project, with Sterling and Wilson tasked with handling everything from design and engineering to procurement and construction (BOS). And they’re not just walking away after the build—the contract includes three years of comprehensive operations and maintenance (O&M), solidifying their role in the project’s lifecycle. The company’s pedigree backs up the confidence: a whopping 20.7 GWp portfolio in utility-scale solar, floating solar, and hybrid projects, along with a 7.8 GWp O&M portfolio, including projects built by others. By mid-morning, shares were still glowing, trading 3.74% higher at ₹460.15 and pushing the company’s market cap to ₹10,745 crore. It’s a much-needed boost for investors banking on the renewable energy story, as Sterling and Wilson keeps proving it’s a major player in India’s green energy drive.

Insurance Stocks Slip as GST Decision Faces Another Delay

Shares of life insurance players took a nosedive as the GST Council pumped the brakes on a potential rate cut for insurance premiums.  New India Assurance slid 6.8% to ₹199.60, and Star Health stumbled by 2.7%. The crux of the market unease? The council, under Finance Minister Nirmala Sitharaman’s watch, decided more time was needed to untangle the tax complexities. Initially, the GoM dangled a promising proposal in November—GST exemptions for term life insurance and reduced rates for health policies catering to senior citizens and those with coverage up to ₹5 lakh. But for now, the standard 18% GST remains on high-ticket health policies exceeding ₹5 lakh, leaving middle-class policyholders and insurers in a limbo. With affordability and accessibility on the line, the eventual outcome of these debates could reshape how millions approach insurance. But as it stands, the market isn’t impressed by the pause.

Proudly powered by WordPress | Theme : News Elementor by BlazeThemes